Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 12,749 clinical trials worldwide
Search
Showing 1-50 of 12,749 trials
Active filters:
Phase: Phase 2
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (12,749)
NCT06974968
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
PHASE2
Not yet recruiting
60 participants
Started: May 25, 2028 · Completed: May 26, 2031
8 conditions
2 sponsors
1 location
NCT05931484
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
PHASE2
Not yet recruiting
32 participants
Started: Nov 1, 2027 · Completed: Nov 1, 2028
1 condition
1 sponsor
0 locations
NCT07170293
Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
PHASE2
Recruiting
15 participants
Started: Aug 31, 2027 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06649747
Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain
PHASE2
Not yet recruiting
408 participants
Started: Apr 1, 2027 · Completed: Mar 31, 2032
1 condition
1 sponsor
0 locations
NCT01777919
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PHASE2
Not yet recruiting
32 participants
Started: Jan 31, 2027 · Completed: Jan 31, 2030
1 condition
4 sponsors
1 location
NCT07131306
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial
PHASE2
Not yet recruiting
100 participants
Started: Jan 31, 2027 · Completed: Aug 31, 2031
1 condition
2 sponsors
1 location
NCT05402384
AVTX-801 D-galactose Supplementation in SLC35A2-CDG
PHASE2
Not yet recruiting
10 participants
Started: Jan 31, 2027 · Completed: Mar 31, 2028
1 condition
4 sponsors
1 location
NCT06180616
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
PHASE2
Not yet recruiting
40 participants
Started: Dec 31, 2026 · Completed: Dec 31, 2028
2 conditions
1 sponsor
0 locations
NCT05039892
Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma
PHASE2
Not yet recruiting
50 participants
Started: Dec 31, 2026 · Completed: Jun 30, 2028
1 condition
1 sponsor
0 locations
NCT06196671
Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer
PHASE2
Not yet recruiting
30 participants
Started: Dec 1, 2026 · Completed: Jan 1, 2028
1 condition
1 sponsor
0 locations
NCT06251609
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
PHASE2
Not yet recruiting
98 participants
Started: Nov 30, 2026 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT06848673
Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI
PHASE2
Not yet recruiting
100 participants
Started: Nov 1, 2026 · Completed: Sep 30, 2028
1 condition
1 sponsor
0 locations
NCT07112456
Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations
PHASE2
Not yet recruiting
100 participants
Started: Sep 1, 2026 · Completed: Aug 31, 2029
3 conditions
1 sponsor
0 locations
NCT05199077
A Study of GM-XANTHO in Pressure Ulcer Patients
PHASE2
Not yet recruiting
58 participants
Started: Sep 1, 2026 · Completed: Apr 30, 2029
2 conditions
2 sponsors
1 location
NCT07218692
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
PHASE2
Not yet recruiting
35 participants
Started: Aug 11, 2026 · Completed: Aug 11, 2027
9 conditions
2 sponsors
2 locations
NCT06832865
ELISA in Relapsed/Refractory MM
PHASE2
Not yet recruiting
30 participants
Started: Aug 1, 2026 · Completed: Dec 1, 2028
2 conditions
3 sponsors
2 locations
NCT06463678
Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
PHASE2
Not yet recruiting
60 participants
Started: Aug 1, 2026 · Completed: Dec 31, 2027
1 condition
1 sponsor
0 locations
NCT06226662
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
PHASE2
Not yet recruiting
12 participants
Started: Jun 30, 2026 · Completed: Sep 30, 2028
1 condition
1 sponsor
0 locations
NCT01894308
A Dose Ranging Study to Examine TDS-Testosterone 5%
PHASE2
Not yet recruiting
48 participants
Started: Jun 30, 2026 · Completed: Feb 28, 2027
1 condition
2 sponsors
1 location
NCT06518941
An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa
PHASE2
Not yet recruiting
10 participants
Started: Jun 30, 2026 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06887738
Study of NM8074 in Patients with Dermatomyositis (DM)
PHASE2
Not yet recruiting
8 participants
Started: Jun 30, 2026 · Completed: Dec 31, 2028
1 condition
1 sponsor
0 locations
NCT05545891
Aripiprazole in Body Focused Repetitive Behaviors
PHASE2
Not yet recruiting
100 participants
Started: Jun 30, 2026 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05054790
Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct
PHASE2
Not yet recruiting
10 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05921227
Addressing Treatment Nonresponders
PHASE2
Not yet recruiting
16 participants
Started: Jun 30, 2026 · Completed: Aug 31, 2027
1 condition
2 sponsors
0 locations
NCT05731050
Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
PHASE2
Not yet recruiting
6 participants
Started: Jun 30, 2026 · Completed: Mar 31, 2028
1 condition
1 sponsor
0 locations
NCT05423197
89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC
PHASE2
Not yet recruiting
60 participants
Started: Jun 30, 2026 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06733519
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
PHASE2
Not yet recruiting
40 participants
Started: Jun 1, 2026 · Completed: Jun 1, 2027
2 conditions
1 sponsor
0 locations
NCT07061964
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
PHASE2
Recruiting
111 participants
Started: Jun 1, 2026 · Completed: Jul 31, 2027
3 conditions
1 sponsor
15 locations
NCT06985498
CD22/CD19 CAR-T and Blinatumomab Combined With Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
PHASE2
Not yet recruiting
40 participants
Started: Jun 1, 2026 · Completed: Sep 1, 2029
1 condition
1 sponsor
0 locations
NCT01677689
Study to Investigate the Efficacy and Safety of Apomivir®
PHASE2
Not yet recruiting
196 participants
Started: May 31, 2026 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT07081763
Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption
PHASE2
Not yet recruiting
191 participants
Started: May 31, 2026 · Completed: Nov 30, 2030
1 condition
1 sponsor
0 locations
NCT06057831
PET/MRI in Rectal Cancer
PHASE2
Not yet recruiting
40 participants
Started: May 31, 2026 · Completed: Dec 31, 2030
1 condition
1 sponsor
0 locations
NCT07203053
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
PHASE2
Not yet recruiting
48 participants
Started: May 31, 2026 · Completed: Oct 31, 2029
1 condition
2 sponsors
0 locations
NCT07218666
Zanzalintinib in Men With Aggressive Variant Prostate Cancer
PHASE2
Not yet recruiting
30 participants
Started: May 31, 2026 · Completed: Dec 31, 2027
1 condition
3 sponsors
0 locations
NCT07193550
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
PHASE2
Not yet recruiting
70 participants
Started: May 31, 2026 · Completed: Oct 31, 2031
1 condition
2 sponsors
1 location
NCT05729503
Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals
PHASE2
Not yet recruiting
70 participants
Started: May 6, 2026 · Completed: Dec 1, 2026
1 condition
1 sponsor
4 locations
NCT07037004
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
PHASE2
Not yet recruiting
62 participants
Started: May 4, 2026 · Completed: May 4, 2027
5 conditions
2 sponsors
2 locations
NCT07179120
Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
PHASE2
Not yet recruiting
180 participants
Started: May 1, 2026 · Completed: Jan 2, 2027
1 condition
1 sponsor
0 locations
NCT06210854
Assessing Jet Administration of pBI-11 for the Treatment of Patients With HPV16/18+
PHASE2
Not yet recruiting
72 participants
Started: May 1, 2026 · Completed: Oct 1, 2028
1 condition
1 sponsor
0 locations
NCT06667726
An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
PHASE2
Not yet recruiting
47 participants
Started: May 1, 2026 · Completed: Oct 8, 2029
1 condition
1 sponsor
1 location
NCT07205796
A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
PHASE2
Not yet recruiting
480 participants
Started: May 1, 2026 · Completed: Dec 30, 2027
1 condition
1 sponsor
0 locations
NCT07215403
Prescriptive Infusion Algorithm (PIA)
PHASE2
Not yet recruiting
12 participants
Started: May 1, 2026 · Completed: Mar 1, 2028
1 condition
2 sponsors
0 locations
NCT07178938
Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases
PHASE2
Not yet recruiting
10 participants
Started: Apr 30, 2026 · Completed: Dec 31, 2028
2 conditions
1 sponsor
0 locations
NCT05646524
Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
PHASE2
Not yet recruiting
12 participants
Started: Apr 30, 2026 · Completed: Sep 30, 2028
1 condition
1 sponsor
0 locations
NCT02988297
Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
PHASE2
Not yet recruiting
140 participants
Started: Apr 30, 2026 · Completed: May 31, 2028
1 condition
1 sponsor
0 locations
NCT07138274
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
PHASE2
Not yet recruiting
90 participants
Started: Apr 30, 2026 · Completed: Dec 31, 2031
2 conditions
1 sponsor
0 locations
NCT07179003
A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses
PHASE2
Not yet recruiting
50 participants
Started: Apr 30, 2026 · Completed: Mar 31, 2031
1 condition
1 sponsor
1 location
NCT07211438
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
PHASE2
Not yet recruiting
40 participants
Started: Apr 1, 2026 · Completed: Dec 1, 2028
1 condition
2 sponsors
2 locations
NCT07187011
Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans
PHASE2
Not yet recruiting
120 participants
Started: Apr 1, 2026 · Completed: May 1, 2029
1 condition
3 sponsors
2 locations
NCT07189585
Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis
PHASE2
Not yet recruiting
84 participants
Started: Apr 1, 2026 · Completed: Jul 31, 2027
1 condition
3 sponsors
1 location
«
Previous
1
2
2
3
4
More pages
255
Next